Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Breast Cancer Research : BCR|February 14, 2006
Recent translational research: oncogene discovery by insertional mutagenesis gets a new boostJohn Hilkens
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 12, 2003
Tumor-host interactions regulate glucocorticoid-mediated epiglycanin expression in TA3Ha murine mammary carcinoma cellsTorunn Thingstad, John Hilkens
Molecular & Cellular Oncology|April 13, 2017
Insulin receptor substrate 4 (IRS4) is a constitutive active oncogenic driver collaborating with HER2 and causing therapeutic resistanceGerjon J Ikink, John Hilkens
Oncology Reports|December 22, 2007
Ether lipid 1-O-octadecyl-2-O-methyl-3-glycero-phosphocholine inhibits cell-cell adhesion through translocation and clustering of E-cadherin and episialin in membrane microdomainsSeverine Van Slambrouck, John Hilkens, Wim F A Steelant
Nature Communications|November 24, 2016
IRS4 induces mammary tumorigenesis and confers resistance to HER2-targeted therapy through constitutive PI3K/AKT-pathway hyperactivationGerjon J Ikink, Mandy Boer, Elvira R M Bakker, et al.
International Journal of Oncology|September 3, 2009
AsialoGM1 and integrin alpha2beta1 mediate prostate cancer progressionSeverine Van Slambrouck, John Hilkens, Marco Bisoffi, et al.
Oncogene|June 23, 2004
Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomasVassiliki Theodorou, Mandy Boer, Britta Weigelt, et al.
Nature Genetics|May 1, 2007
MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancerVassiliki Theodorou, Melanie A Kimm, Mandy Boer, et al.
Cell Death and Differentiation|July 22, 2017
Interaction of galectin-3 with MUC1 on cell surface promotes EGFR dimerization and activation in human epithelial cancer cellsTushar Piyush, Anisha R Chacko, Paulina Sindrewicz, et al.
Molecular Cancer|June 23, 2010
Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikisQicheng Zhao, Monica Barclay, John Hilkens, et al.
Pageof 3